Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering

Rina Mikhailovna Zaslavskaya; Galina Victorovna Lilitsa; G. S. Dilmagambetova; Franz Halberg; Germaine G Cornelissen-Guillaume; Kuniaki Otsuka; Ram B. Singh; Alexander Stoynev; Ognian Ikonomov; Roberto Tarquini; Federico Perfetto; Othild Schwartzkopff; Earl E. Bakken

doi:10.1016/S0753-3322(04)80021-0

Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering

Rina Mikhailovna Zaslavskaya
, Galina Victorovna Lilitsa
, G. S. Dilmagambetova
, Franz Halberg
, Germaine G Cornelissen-Guillaume
, Kuniaki Otsuka
, Ram B. Singh
, Alexander Stoynev
, Ognian Ikonomov
, Roberto Tarquini
, Federico Perfetto
, Othild Schwartzkopff
, Earl E. Bakken

Physiology

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.

Original language	English (US)
Pages (from-to)	S129-S134
Journal	Biomedicine and Pharmacotherapy
Volume	58
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0753-3322(04)80021-0
State	Published - Oct 2004

Bibliographical note

Funding Information:
This study was supported by the US National Institutes of Health (GM-13981), and the University of Minnesota Supercomputing Institute.

Keywords

Conventional treatment
Drug-refractory hypertension
MESOR-hypertension
Melatonin

Publisher link

10.1016/S0753-3322(04)80021-0

Find It

Find It at U of M Libraries

Cite this

Zaslavskaya, R. M., Lilitsa, G. V., Dilmagambetova, G. S., Halberg, F., Cornelissen-Guillaume, G. G., Otsuka, K., Singh, R. B., Stoynev, A., Ikonomov, O., Tarquini, R., Perfetto, F., Schwartzkopff, O., & Bakken, E. E. (2004). Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering. Biomedicine and Pharmacotherapy, 58(SUPPL. 1), S129-S134. https://doi.org/10.1016/S0753-3322(04)80021-0

Zaslavskaya, RM, Lilitsa, GV, Dilmagambetova, GS, Halberg, F, Cornelissen-Guillaume, GG, Otsuka, K, Singh, RB, Stoynev, A, Ikonomov, O, Tarquini, R, Perfetto, F, Schwartzkopff, O & Bakken, EE 2004, 'Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering', Biomedicine and Pharmacotherapy, vol. 58, no. SUPPL. 1, pp. S129-S134. https://doi.org/10.1016/S0753-3322(04)80021-0

@article{3db80603bb2147b3aaa1bc0940adeb1f,

title = "Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering",

abstract = "A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.",

keywords = "Conventional treatment, Drug-refractory hypertension, MESOR-hypertension, Melatonin",

author = "Zaslavskaya, \{Rina Mikhailovna\} and Lilitsa, \{Galina Victorovna\} and Dilmagambetova, \{G. S.\} and Franz Halberg and Cornelissen-Guillaume, \{Germaine G\} and Kuniaki Otsuka and Singh, \{Ram B.\} and Alexander Stoynev and Ognian Ikonomov and Roberto Tarquini and Federico Perfetto and Othild Schwartzkopff and Bakken, \{Earl E.\}",

note = "Funding Information: This study was supported by the US National Institutes of Health (GM-13981), and the University of Minnesota Supercomputing Institute.",

year = "2004",

month = oct,

doi = "10.1016/S0753-3322(04)80021-0",

language = "English (US)",

volume = "58",

pages = "S129--S134",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering

AU - Zaslavskaya, Rina Mikhailovna

AU - Lilitsa, Galina Victorovna

AU - Dilmagambetova, G. S.

AU - Halberg, Franz

AU - Cornelissen-Guillaume, Germaine G

AU - Otsuka, Kuniaki

AU - Singh, Ram B.

AU - Stoynev, Alexander

AU - Ikonomov, Ognian

AU - Tarquini, Roberto

AU - Perfetto, Federico

AU - Schwartzkopff, Othild

AU - Bakken, Earl E.

N1 - Funding Information: This study was supported by the US National Institutes of Health (GM-13981), and the University of Minnesota Supercomputing Institute.

PY - 2004/10

Y1 - 2004/10

N2 - A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.

AB - A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.

KW - Conventional treatment

KW - Drug-refractory hypertension

KW - MESOR-hypertension

KW - Melatonin

UR - https://www.scopus.com/pages/publications/22144479742

UR - https://www.scopus.com/pages/publications/22144479742#tab=citedBy

U2 - 10.1016/S0753-3322(04)80021-0

DO - 10.1016/S0753-3322(04)80021-0

M3 - Article

C2 - 15754851

AN - SCOPUS:22144479742

SN - 0753-3322

VL - 58

SP - S129-S134

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

IS - SUPPL. 1

ER -

Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this